Alemtuzumab Compared With Chlorambucil As First-Line Therapy for Chronic Lymphocytic LeukemiaPeter Hillmen, Jiřı́ Mayer, Branimir Jakšić et al.|Journal of Clinical Oncology|2007Cited by 556